Professor and director of the Andrology Laboratory University of British Columbia Canada
Dr. Gregory Lee is professor and director of the Andrology Laboratory at the University of British Columbia, Canada. He received his Ph.D. degree in Biophysical Chemistry at California Institute of Technology in 1972 joined UCSD as a NIH Postdoctoral Fellow to carry out pioneer work on general ligand affinity chromatography. In 1976, he studied enzymology and biochemical genetics at the National Institute of Health and in 1981. Dr. Gregory Lee has been serving as an editorial board member for Journal of Cancer Science and Therapy, American Journal of Cancer Review, American Journal of Cancer Science, and Journal of Biochemistry and Physiology. Dr. Gregory Lee research interests include numerous monoclonal antibodies for diagnostic and therapeutic applications in human health care, including RP215 and GHR106 for potential use as anti-cancer drugs.
RP215 and GHR106 for potential use as anti-cancer drugs, Numerous monoclonal antibodies